USD
$0.00
(0.00%
)At Close (As of Oct 14, 2025)
$96.47M
Market Cap
0.452
P/E Ratio
10.93
EPS
$21.40
52 Week High
$2.12
52 Week Low
HEALTHCARE
Sector
Field | Value (None) |
---|---|
Gross Profit | - |
Total Revenue | - |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$1.1B |
Selling General And Administrative | $7.8B |
Research And Development | $9B |
Operating Expenses | $17B |
Investment Income Net | - |
Net Interest Income | - |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | - |
Income Before Tax | -$838M |
Income Tax Expense | -$468M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | - |
Comprehensive Income Net Of Tax | - |
Ebit | - |
Ebitda | -$1.1B |
Net Income | -$370M |
Field | Value (None) |
---|---|
Total Assets | $29B |
Total Current Assets | $15B |
Cash And Cash Equivalents At Carrying Value | $14B |
Cash And Short Term Investments | $14B |
Inventory | - |
Current Net Receivables | $12M |
Total Non Current Assets | $14B |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $4.8B |
Intangible Assets Excluding Goodwill | $4.8B |
Goodwill | $8.6B |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $818M |
Other Non Current Assets | - |
Total Liabilities | $9.6B |
Total Current Liabilities | $4.2B |
Current Accounts Payable | $1.2B |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $116M |
Total Non Current Liabilities | $5.4B |
Capital Lease Obligations | - |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $116M |
Other Current Liabilities | $3B |
Other Non Current Liabilities | - |
Total Shareholder Equity | $19B |
Treasury Stock | - |
Retained Earnings | -$178B |
Common Stock | $19K |
Common Stock Shares Outstanding | $1.6B |
Field | Value (None) |
---|---|
Operating Cashflow | $77M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $663M |
Capital Expenditures | $0 |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | - |
Cashflow From Financing | $1.5B |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$370M |
Field | Value (None) |
---|---|
Gross Profit | - |
Total Revenue | - |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$1.1B |
Selling General And Administrative | $7.8B |
Research And Development | $9B |
Operating Expenses | $17B |
Investment Income Net | - |
Net Interest Income | - |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | - |
Income Before Tax | -$838M |
Income Tax Expense | -$468M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | - |
Comprehensive Income Net Of Tax | - |
Ebit | - |
Ebitda | -$1.1B |
Net Income | -$370M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
None